J Sun, Y Xiao, W Xing,
W Jiang, X Hu, H Li, Z Liu… - Biomedicine & …, 2024 - Elsevier
Background and purpose GLP-1 receptor agonists are clinically utilized for type 2 diabetes
and obesity. In vitro and in vivo preclinical studies were performed to assess the druggability …